# NLRP3‐Caspase‐1 Axis in Human Adipose Tissue Crown‐Like Structures: A Potential Mediator of Inflammation and the Effects of Bariatric Surgery

**Authors:** Ville A. Palomäki, Juha P. Väyrynen, Vesa Koivukangas, Sanna Meriläinen, Tuomo J. Karttunen, Petri Lehenkari

PMC · DOI: 10.1002/iid3.70312 · Immunity, Inflammation and Disease · 2026-02-05

## TL;DR

The NLRP3-Caspase-1 pathway in fat tissue macrophages may drive obesity-related inflammation and improve after bariatric surgery.

## Contribution

This study identifies the NLRP3-Caspase-1 axis in crown-like structures as a potential mediator of inflammation and metabolic benefits of bariatric surgery.

## Key findings

- NLRP3 and Caspase-1 are expressed in macrophages within crown-like structures and single macrophages in subcutaneous adipose tissue.
- Bariatric surgery reduces the number of macrophages expressing NLRP3 and Caspase-1 in adipose tissue.
- NLRP3 and Caspase-1 are also found in the endothelium of vascular structures in adipose tissue.

## Abstract

Obesity‐related comorbidities, such as type 2 diabetes, are associated with chronic inflammation mediated by macrophages. This inflammation is characterized by the accumulation of macrophages in crown‐like structures (CLS) surrounding dead adipocytes within adipose tissue. In a recent study, we reported a significant reduction in CLS‐associated macrophages following bariatric surgery. The NLRP3 inflammasome and its downstream effector, Caspase‐1, are well‐established mediators of metabolic dysfunction and inflammation in obesity.

Immunohistochemical single‐ and multiplex staining of subcutaneous adipose tissue (SAT) samples from patients with obesity was performed to characterize the detailed distribution of NLRP3 and Caspase‐1. The samples were collected during gastric bypass surgery and at a 1‐year follow‐up.

Both NLRP3 and Caspase‐1 were expressed by CD68‐positive macrophages in SAT including both single macrophages and those forming CLS. A reduction in the total number of SAT macrophages expressing these proteins was detected following gastric bypass. Furthermore, NLRP3 and Caspse‐1 were observed in the endothelium of vascular structures.

Our findings demonstrate that both CLS‐forming and single cell macrophage populations in human adipose tissue express NLRP3 and Caspase‐1. The study highlights the significance of the NLRP3 inflammasome macrophages in the pathogenesis of adipose tissue inflammation in obesity. The previously reported abundance of CLS in untreated obesity and their reduction after bariatric surgery suggest that the NLRP3‐Caspase‐1 axis within CLS may serve as an important mediator of the beneficial metabolic effects associated with bariatric surgery.

NLRP3 and Caspase‐1 are mainly expressed in subcutaneous adipose tissue macrophages and are highly enriched in CLS. The NLRP3‐caspase‐1 axis in CLS may be a key mediator of obesity‐associated inflammation of adipose tissue and may explain some of the beneficial metabolic and anti‐inflammatory effects of bariatric surgery.

## Linked entities

- **Genes:** NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548], Caspase1 (caspase-1) [NCBI Gene 692604], CD68 (CD68 molecule) [NCBI Gene 968]
- **Proteins:** NLRP3 (NLR family pyrin domain containing 3), Caspase1 (caspase-1), CD68 (CD68 molecule)
- **Diseases:** type 2 diabetes (MONDO:0005148), obesity (MONDO:0011122)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** SAT1 (spermidine/spermine N1-acetyltransferase 1) [NCBI Gene 6303] {aka DC21, KFSD, KFSDX, SAT, SSAT, SSAT-1}, NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}, IL18 (interleukin 18) [NCBI Gene 3606] {aka IGIF, IL-18, IL-1g, IL1F4}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, CD68 (CD68 molecule) [NCBI Gene 968] {aka GP110, LAMP4, SCARD1}, CASP1 (caspase 1) [NCBI Gene 834] {aka ICE, IL1BC, P45}, PGM1 (phosphoglucomutase 1) [NCBI Gene 5236] {aka CDG1T, GSD14}
- **Diseases:** type 2 diabetes (MESH:D003924), loss (MESH:D016388), Obesity (MESH:D009765), osteoarthritis (MESH:D010003), visceral obesity (MESH:D056128), necrosis (MESH:D009336), impaired glucose metabolism (MESH:D044882), Inflammation (MESH:D007249), weight gain (MESH:D015430), metabolic dysfunction (MESH:D008659), insulin resistance (MESH:D007333), metabolic disturbances (MESH:D024821), CLS (MESH:D000072717), Weight loss (MESH:D015431)
- **Chemicals:** AMEC Red (-), citrate (MESH:D019343), free fatty acids (MESH:D005230), 3,3'-Diaminobenzidine (MESH:D015100), formalin (MESH:D005557), lipid (MESH:D008055), hematoxylin (MESH:D006416), paraffin (MESH:D010232), DAB (MESH:C000469), water (MESH:D014867), ethanol (MESH:D000431), H&amp;E (MESH:D006371), ATP (MESH:D000255), eosin (MESH:D004801)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12877315/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12877315/full.md

## References

44 references — full list in the complete paper: https://tomesphere.com/paper/PMC12877315/full.md

---
Source: https://tomesphere.com/paper/PMC12877315